Search

everythinglearnresearchcommunity

for

Search:↓

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

The research found that a specific skin cell type not only triggers hair growth but also controls hair color, and that aging can lead to hair loss and color changes.

Researchers found that the Leptin receptor is a consistent marker for hair follicle dermal cells, which may help future hair research.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

The research found that the gene activity in mouse skin stem cells changes significantly as they age.

Lactate production is important for activating hair growth stem cells.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Using neurohormones to control keratin can lead to new skin disease treatments.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

Non-coding RNAs play key roles in the hair growth cycle of Angora rabbits.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Ruxolitinib treatment may cause eyelash growth.

Hair growth environment recreated with challenges; stem cells make successful skin organoids.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Gray hair can potentially be reversed, leading to new treatments.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Rhamnose may help hair growth and pigmentation, making it a potential treatment for hair loss.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.